2027 Medicare Advantage Final Rule, Rate Released
CMS finalized the 2027 Medicare Advantage and Part D rule, updating benefits, cost sharing, Star Ratings policies, and payment rates for plans.
Read moreThe American College of Radiology® (ACR®) prepared a detailed summary of the Contract Year 2026 Policy and Technical Changes to the Medicare Advantage (MA) Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly final rule released April 4 by the Centers for Medicare and Medicaid Services (CMS).
Notably, CMS did not finalize the proposal to establish new guardrails for artificial intelligence (AI) in the MA program to ensure services are provided equitably irrespective of delivery method or origin, whether from human or automated systems. CMS stated within the rule that they “acknowledge the broad interest in regulation of AI and will continue to consider the extent to which it may be appropriate to engage in future rulemaking in this area.”
Additional topics covered in the ACR summary include improving experiences for dually eligible enrollees, clarifying payment determinations made by MA organizations and risk adjustment updates.
The regulations outlined in the rule take effect June 3, and the provisions are applicable to coverage beginning Jan. 1, 2026 (except as otherwise noted within the rule). More information can be found in the agency’s fact sheet.
If you have questions, contact Kimberly Greck, ACR Senior Economic Policy Analyst.
2027 Medicare Advantage Final Rule, Rate Released
CMS finalized the 2027 Medicare Advantage and Part D rule, updating benefits, cost sharing, Star Ratings policies, and payment rates for plans.
Read morePhysician Groups Warn Visa Delays Could Impact Patient Care
More than 30 medical organizations, including the ACR®️, urged federal officials to address immigration barriers preventing international medical graduates (IMGs) from lawfully entering or remaining in the U.S.
Read moreACR Submits Testimony to Congress
ACR®️ submitted testimony to the U.S. House Committee on Appropriations Labor urging strong federal funding for medical research in federal fiscal year 2027.
Read more